#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Graft versus host disease Chronic graft versus host disease in intestine Acute myeloid leukaemia recurrent Marginal zone lymphoma refractory Haemophilia A with anti factor VIII Orthostatic hypotension Acute myeloid leukaemia Desmoid tumour Behcet's syndrome Lip and/or oral cavity cancer Friedreich's ataxia Thrombocytosis Leber's congenital amaurosis White matter lesion Multiple system atrophy More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome – Life with Disease Congenital hypotransferrinaemia – Diagnostics Nephroblastoma – Trials in Disease Systemic sclerosis pulmonary – Diagnostics Medulloblastoma recurrent – Basic Information Pelizaeus-Merzbacher disease – Basic Information Primary biliary cholangitis – Basic Information Primary immunodeficiency syndrome – Trials in Disease Bronchopulmonary dysplasia – Basic Information Krabbe’s disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Palivizumab Belumosudil Mesilate Prednisolone Sodium Succinate Viltolarsen Siponimod Fumaric Acid Tumour Detection Mometasone Trastuzumab Emtansine Jnj-81241459 Vgl101 Nitrous Oxide M1P Dipotassium Salt Tecaginlimab USNOFLAST Mk-2060 Glucose Monohydrate Ph. Eur. Ketotifen Hydrogen Fumarate Rasburicase Cortisone Acetate 68Ganota-Anti-Her2 Vhh1 More therapies…

    Learn about Your Condition

    Sickle cell anaemia Lymphocytic leukaemia Small intestine carcinoma Mental disorder Post cardiac arrest syndrome Vulval cancer Oesophagogastroscopy Pericarditis Endometriosis Mantle cell lymphoma Hypoaesthesia Barrett's oesophagus Metastases to peritoneum Porphyria non-acute Hypochondroplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study of SAR445399 in Adults Aged 18‑80 with Non‑cystic Fibrosis Bronchiectasis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • SAR445399
    France Germany The Netherlands Poland Spain

  • Study of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Enfortumab Vedotin
    • Pembrolizumab
    France Germany Italy Poland Spain

  • Supplementary Oxygen Therapy for Patients with Fracture-Related Infection After Limb Debridement and Reconstruction Surgery: A Pilot Randomized Trial

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Fracture infection
    Investigated Drugs:
    • Oxygen
    The Netherlands

  • Long‑Term Monitoring of Malignancy Risk in Early‑Onset Metachromatic Leukodystrophy Patients Treated with atidarsagene autotemcel

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metachromatic leukodystrophy
    Investigated Drugs:
    • Atidarsagene Autotemcel
    France Germany Italy The Netherlands Sweden

  • A Randomized Double‑Blind Placebo‑Controlled Study of TAK‑360 in Adults with Narcolepsy with Cataplexy (Type 1)

    Not yet recruiting

    2 1
    France Italy Spain

  • Feasibility and Safety of PEX010 Psilocybin Capsules (5 mg and 25 mg) in Military Veterans with Posttraumatic Stress Disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    The Netherlands
Previous Page
1 … 691 692 693 694 695 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!